JPH0456839B2 - - Google Patents
Info
- Publication number
- JPH0456839B2 JPH0456839B2 JP60036061A JP3606185A JPH0456839B2 JP H0456839 B2 JPH0456839 B2 JP H0456839B2 JP 60036061 A JP60036061 A JP 60036061A JP 3606185 A JP3606185 A JP 3606185A JP H0456839 B2 JPH0456839 B2 JP H0456839B2
- Authority
- JP
- Japan
- Prior art keywords
- cycloartenol
- ester
- polyvinylpyrrolidone
- coprecipitate
- ferulate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 claims description 33
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 23
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 23
- -1 cycloartenol ferulate ester Chemical class 0.000 claims description 15
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- 239000007788 liquid Substances 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 210000001035 gastrointestinal tract Anatomy 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000010586 diagram Methods 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 230000001766 physiological effect Effects 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 238000004566 IR spectroscopy Methods 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000007922 dissolution test Methods 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- CHRHZFQUDFAQEQ-UHFFFAOYSA-L calcium;2-hydroxyacetate Chemical compound [Ca+2].OCC([O-])=O.OCC([O-])=O CHRHZFQUDFAQEQ-UHFFFAOYSA-L 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 150000001793 charged compounds Chemical class 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
Landscapes
- Compositions Of Macromolecular Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3606185A JPS61194022A (ja) | 1985-02-23 | 1985-02-23 | シクロアルテノ−ルフエルラ酸エステル−ポリビニルピロリドン共沈体 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3606185A JPS61194022A (ja) | 1985-02-23 | 1985-02-23 | シクロアルテノ−ルフエルラ酸エステル−ポリビニルピロリドン共沈体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61194022A JPS61194022A (ja) | 1986-08-28 |
| JPH0456839B2 true JPH0456839B2 (uk) | 1992-09-09 |
Family
ID=12459197
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3606185A Granted JPS61194022A (ja) | 1985-02-23 | 1985-02-23 | シクロアルテノ−ルフエルラ酸エステル−ポリビニルピロリドン共沈体 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61194022A (uk) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100309870B1 (ko) * | 1998-09-18 | 2001-12-28 | 민경윤 | 수난용성 hmg-coa 환원효소 저해제 조성물 |
| US6310100B1 (en) * | 1999-09-22 | 2001-10-30 | Kao Corporation | Method of treating hypertension |
| US6991812B2 (en) | 2000-09-05 | 2006-01-31 | Kao Corporation | Agent for preventing, improving or treating hypertension |
| CN102125566B (zh) * | 2011-01-11 | 2013-05-22 | 北京世纪博康医药科技有限公司 | 一种环木菠萝烯醇阿魏酸酯的药物组合物 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5531010A (en) * | 1978-08-25 | 1980-03-05 | Okayasu Shoten:Kk | Alkali metal salt of cycloartenol succinic acid ester |
| JPS5942313A (ja) * | 1982-09-01 | 1984-03-08 | Teijin Ltd | ポリビニルポリピロリドンを用いた製剤 |
-
1985
- 1985-02-23 JP JP3606185A patent/JPS61194022A/ja active Granted
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5531010A (en) * | 1978-08-25 | 1980-03-05 | Okayasu Shoten:Kk | Alkali metal salt of cycloartenol succinic acid ester |
| JPS5942313A (ja) * | 1982-09-01 | 1984-03-08 | Teijin Ltd | ポリビニルポリピロリドンを用いた製剤 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61194022A (ja) | 1986-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5529745B2 (ja) | 新規なマンゴー配糖体カルシウム塩、その製造方法及びその使用 | |
| WO2017133465A1 (zh) | 一种黄芩苷镁化合物及其制备方法与它的用途 | |
| AU2022203369B2 (en) | Analogs of deutetrabenazine, their preparation and use | |
| CN111148729A (zh) | 苯烯莫德的晶型及其用途与制备方法 | |
| BG63288B1 (bg) | Смеси, добивани от зърна на еugеniа jамвоlаnа lамаrск, получаване и използване на посочените смеси и някои техни компоненти като лекарства | |
| WO2008145064A1 (fr) | Procédé d'obtention d'un extrait contenant du séquoyitol à partir d'une espèce du genre trifolium, de soja et de ginkgo biloba, et utilisation de celui-ci | |
| CN109400598B (zh) | 盐酸小檗碱与乳酸共晶、其制备方法和应用 | |
| CN103159774B (zh) | 一种马钱子总碱的提取分离纯化方法 | |
| JPH0456839B2 (uk) | ||
| WO2004039759A1 (fr) | Compose naturel servant dans le traitement de diabetes, sa preparation et son utilisation | |
| CN102670670B (zh) | 一种高银杏萜类内酯含量的银杏达莫注射液的制备方法 | |
| WO2017076169A1 (zh) | 黄芩素咖啡因共晶、其制备方法、药物组合物及其应用 | |
| Zeng et al. | Rapid profiling of cantharidin analogs in Mylabris phalerata Pallas by ultra‐performance liquid chromatography–quadrupole time‐of‐flight–tandem mass spectrometry | |
| Wang et al. | Microcrystalline preparation of akebia saponin D for its bioavailability enhancement in rats | |
| CN114394931B (zh) | 具有血管舒张活性的单萜生物碱及其提取方法和应用 | |
| CN111825646B (zh) | 一种丁基苯肽类化合物及其制备方法和应用 | |
| CN108484709A (zh) | 灯盏花乙素镁化合物、其制备方法及应用 | |
| CN102020602B (zh) | 盐酸乐卡地平晶型及其制备方法和含有该晶型的药物组合物 | |
| Cassels et al. | Boldine | |
| CN118084930A (zh) | 苯酞异喹啉类生物碱及其药学上可接受的盐及其应用、药物组合物及其应用 | |
| Liu et al. | Quercetin-phospholipids complex solid dispersion and quercetin solid dispersion: preparation and evaluation. | |
| CN107286210B (zh) | 一种乙酰天麻素化合物及其制备方法、制剂与应用 | |
| CN113402390A (zh) | 一种阿司匹林药物共晶体及其制备方法和应用 | |
| KR100553995B1 (ko) | 아실-코에이:콜레스테롤 전이효소 저해활성을 갖는 아자벤조 안트라센계 화합물 | |
| KR20220088743A (ko) | 저산소 유발 인자-프롤릴 하이드록실라제 억제제의 결정 형태 |